Regulation of the mevalonate pathway
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
The mevalonate pathway produces isoprenoids that are vital for diverse cellular functions, ranging from cholesterol synthesis to growth control. Several mechanisms for feedback regulation of low-density-lipoprotein receptors and of two enzymes involved in mevalonate biosynthesis ensure the production of sufficient mevalonate for several end-products. Manipulation of this regulatory system could be useful in treating certain forms of cancer as well as heart disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conversion of acetyl-coenzyme A (CoA) to farnesyl diphosphate (FPP) is commonly referred to as the isoprenoid pathway, in which P-hydroxy-P-methylglutaryl(HMG)-CoA reductase is the major site of regulation [5].”
In the citing paper
“Since HMGCR encodes the rate-limiting enzyme of the cholesterol biosynthesis pathway and is tightly regulated at the level of gene transcription by sterol response element binding factor 2 (SREBF2) in response to changes in intracellular sterol content10, we identified genes whose statin-induced expression level changes were most highly correlated with statin-induced changes in HMGCR.”
From Transmembrane Protein 55B Is a Novel Regulator of Cellular Cholesterol Metabolism (2014) · cites this paper as [10]
In the citing paper
“The expression of liver LDL receptor (LDLR) regulates human plasma LDL-cholesterol (LDL-C) homeostasis”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [3]
In the citing paper
“The liver is the organ responsible for removing >70% to 80% of LDL-c from circulation via LDL receptor (LDLR)–mediated endocytosis.”
In the citing paper
“Therefore, the amount of LDLR expressed on the surface of hepatocytes is a major determinant of LDL-c circulating levels.”
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citationThe Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,799
Brown, M. S., & Goldstein, J. L. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42221-7 · Cited by 1,198
Self-citationPromoter-specific activation of RNA polymerase II transcription by Sp1
Kadonaga, J. T., Jones, K. A., & Tjian, R. (1986) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(86)90226-4 · Cited by 1,012
p21ras is modified by a farnesyl isoprenoid.
Casey, P. J., Solski, P. A., Der, C. J., & Buss, J. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8323 · Cited by 856
Regulation of HMG-CoA Reductase
RODWELL, V. W., NORDSTROM, J. L., & MITSCHELEN, J. J. (1976) · Advances in Lipid Research · doi:10.1016/b978-0-12-024914-5.50008-5 · Cited by 746
Santoro, C., Mermod, N., Andrews, P. C., & Tjian, R. (1988) · Nature · doi:10.1038/334218a0 · Cited by 715
Segev, N., Mulholland, J., & Botstein, D. (1988) · Cell · doi:10.1016/0092-8674(88)90433-3 · Cited by 689
A family of receptors coupled to guanine nucleotide regulatory proteins
Dohlman, H. G., Caron, M. G., & Lefkowitz, R. J. (1987) · Biochemistry · doi:10.1021/bi00384a001 · Cited by 631
Research works printed but not linked: 3
- Smith, J. R., Osborne, T. F., Goldstein, J. L. & Brown, M. S. J. biol. Chem. (in the press).
- Kamiya, Y., Sakurai, A., Tamura, S. & Takahashi, N. Agric. Biol. Chem. 43, 1049–1053 (1979).
- Gibbs, J. B. & Marshall, M. S. Micro. Rev. 53, 171–185 (1989). · doi:10.1128/mr.53.2.171-185.1989 · Paper page
Cited by
Items 1,001–1,062 of 1,062
Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins
Sirvent, P., Fabre, O., Bordenave, S., Hillaire-Buys, D., Raynaud De Mauverger, E., Lacampagne, A., & Mercier, J. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.01.008 · Cited by 90
“By blocking this rate-limiting step in the mevalonate pathway, endogenous de novo synthesis of cholesterol is prevented and low density lipoprotein (LDL) cholesterol uptake into cells is promoted (Goldstein and Brown, 1990).”
BackgroundCoenzyme Q and Its Role in the Dietary Therapy against Aging
Varela-López, A., Giampieri, F., Battino, M., & Quiles, J. (2016) · Molecules · doi:10.3390/molecules21030373 · Cited by 86
“have farnesyl-PP as substrate which are considered to be rate-limiting for the terminal portion of the biosynthetic sequences [93].”
BackgroundStatins and risk of type 2 diabetes: mechanism and clinical implications
Laakso, M., & Fernandes Silva, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1239335 · Cited by 82
“Statins inhibits the HMG-CoA reductase enzyme that suppresses the synthesis of mevalonate, cholesterol, and its downstream metabolites (48, 49).”
BackgroundShea-Eaton, W. K., Trinidad, M. J., Lopez, D., Nackley, A., & McLean, M. P. (2001) · Endocrinology · doi:10.1210/endo.142.4.8075 · Cited by 80
Statins: an essential component in the management of carotid artery disease
Paraskevas, K. I., Hamilton, G., & Mikhailidis, D. P. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.03.035 · Cited by 77
The Efficacy of Squalene in Cardiovascular Disease Risk-A Systematic Review
Ibrahim, N. ‘., Fairus, S., Zulfarina, M. S., & Naina Mohamed, I. (2020) · Nutrients · doi:10.3390/nu12020414 · Cited by 79
“Statins act as the competitive inhibitors of 3‐hydroxy‐3‐methylglutarylcoenzyme A (HMG‐ CoA) reductase at the initial step in cholesterol synthesis, inhibiting the conversion of HMG‐CoA to mevalonate [11,12].”
BackgroundJackson Snipes, G., & Suter, U. (1997) · Subcellular Biochemistry · doi:10.1007/978-1-4615-5901-6_7 · Cited by 77
Scotti, E., Hong, C., Yoshinaga, Y., Tu, Y., Hu, Y., Zelcer, N., Boyadjian, R., de Jong, P. J., Young, S. G., Fong, L. G., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01469-10 · Cited by 77
“In addition, SREBP promotes the expression of the low-density lipoprotein receptor (LDLR), thereby increasing LDL uptake and cholesterol delivery to cells (7).”
BackgroundSUPEROXIDE ANION OVERPRODUCTION IN SEPSIS: EFFECTS OF VITAMIN E AND SIMVASTATIN
Durant, R., Klouche, K., Delbosc, S., Morena, M., Amigues, L., Beraud, J. J., Canaud, B., & Cristol, J. P. (2004) · Shock · doi:10.1097/01.shk.0000129197.46212.7e · Cited by 75
“One hundred microliters of whole blood was diluted in 410 L of DMEM that contained 50 mM HEPES and 10 UI/mL heparin and was incubated for 20 min with 100 L of lucigenin at 37°C (20).”
BackgroundMethodDrug–drug interactions that interfere with statin metabolism
Hirota, T., & Ieiri, I. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1056149 · Cited by 74
“Statins inhibit the synthesis of mevalonate, a rate-limiting step in cholesterol biosynthesis in the liver [1,2], leading to a reduction in plasma LDL-C levels.”
BackgroundFaust, P. L. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10699 · Cited by 71
“Other defects in isoprenoid pathway metabolism and response to mitogens may affect cellular growth (Goldstein and Brown, 1990; Carlberg et al., 1996; Baes et al., 1997).”
BackgroundJurevics, H., Hostettler, J., Barrett, C., Morell, P., & Toews, A. D. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32008-3 · Cited by 71
Tsamandouras, N., Dickinson, G., Guo, Y., Hall, S., Rostami-Hodjegan, A., Galetin, A., & Aarons, L. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.55 · Cited by 68
Goedeke, L., Rotllan, N., Ramírez, C. M., Aranda, J. F., Canfrán-Duque, A., Araldi, E., Fernández-Hernando, A., Langhi, C., de Cabo, R., Baldán, Á., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.09.033 · Cited by 65
“Conversely, when sterol concentrations are low, SREBPs upregulate HMGCR and the LDLR, thereby enhancing LDL clearance from the plasma and ensuring that intracellular cholesterol levels are maintained [10,11].”
HMG-CoA reductase promotes protein prenylation and therefore is indispensible for T-cell survival
Lacher, S. M., Bruttger, J., Kalt, B., Berthelet, J., Rajalingam, K., Wörtge, S., & Waisman, A. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.221 · Cited by 58
“The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGCR) is an endoplasmatic reticulum residing enzyme, which catalyzes the rate-limiting step of cholesterol biosynthesis within the mevalonate pathway.(1) It catalyzes HMG-CoA conversion to mevalonate and can be competitively inhibited by statins such as l…”
BackgroundSong, J. L., Lyons, C. N., Holleman, S., Oliver, B. G., & White, T. C. (2003) · Medical Mycology · doi:10.1080/1369378031000137233 · Cited by 62
Sandhya, V. G., & Rajamohan, T. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.08.030 · Cited by 62
Martínez-Botas, J. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(01)00125-1 · Cited by 57
Tarkowská, D., & Strnad, M. (2016) · Planta · doi:10.1007/s00425-016-2561-z · Cited by 56
Tracking activity and function of microorganisms by stable isotope probing of membrane lipids
Wegener, G., Kellermann, M. Y., & Elvert, M. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.04.022 · Cited by 54
Lammi, C., Bellumori, M., Cecchi, L., Bartolomei, M., Bollati, C., Clodoveo, M. L., Corbo, F., Arnoldi, A., & Mulinacci, N. (2020) · Nutrients · doi:10.3390/nu12061723 · Cited by 53
“In fact, the transcription of the LDLR and the genes that are required for cholesterol and fatty acid synthesis are controlled by membrane-bound transcription factors called SREBPs [3], and the intracellular cholesterol acts with a negative feedback inhibition mechanism.”
BackgroundInfluentialCholesterol: From Feeding to Gene Regulation
Martini, C., & Pallottini, V. (2007) · Genes & Nutrition · doi:10.1007/s12263-007-0049-y · Cited by 53
“pathway, which produces vital isoprenoid end products in addition to cholesterol [33].”
BackgroundThe N-terminal Domain of Tomato 3-Hydroxy-3-methylglutaryl-CoA Reductases
Denbow, C. J., Lång, S., & Cramer, C. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9710 · Cited by 52
Segatto, M., Di Giovanni, A., Marino, M., & Pallottini, V. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24315 · Cited by 52
“Given the importance of HMGR in cholesterol homeostasis maintenance, it is deeply regulated from both short-term and long-term regulations (Goldstein and Brown, 1990).”
Regulation of fatty acid and cholesterol synthesis: co-operation or competition?
Gibbons, G. F. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00034-1 · Cited by 51
Abdullah, M. M. H., Jones, P. J. H., & Eck, P. K. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv016 · Cited by 47
Tam, S. P., Zhang, X., & Koschinsky, M. L. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37595-7 · Cited by 44
Lee, Y.-J., Han, D.-H., Pak, Y. K., & Cho, S. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.11.073 · Cited by 43
“In case of sterol depletion, the ldlr transcription markedly increases, while it decreases in case of sterol accumulation (Goldstein and Brown, 1990; Ellsworth et al., 1994).”
BackgroundNuclear receptors, cholesterol homeostasis and the immune system
Shahoei, S. H., & Nelson, E. R. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.04.013 · Cited by 43
Genome‐wide expression analysis of cells expressing gain of function mutant D374Y‐PCSK9
Ranheim, T., Mattingsdal, M., Lindvall, J. M., Holla, Ø. L., Berge, K. E., Kulseth, M. A., & Leren, T. P. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21519 · Cited by 41
“Recently, we have demonstrated that the intracellular degradation of the LDLR occurs even when endocytosis through clathrin-coated pits has been blocked (Holla et al., 2007).”
BackgroundJiang, C., Diao, F., Sang, Y.-J., Xu, N., Zhu, R.-L., Wang, X.-X., Chen, Z., Tao, W.-W., Yao, B., Sun, H.-X., et al. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006535 · Cited by 39
Johnson, K. A., Endapally, S., Vazquez, D. C., Infante, R. E., & Radhakrishnan, A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010393 · Cited by 39
(2010) · PubMed · Cited by 38
Hinoi, T., Kishida, S., Koyama, S., Ikeda, M., Matsuura, Y., & Kikuchi, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19710 · Cited by 38
Ergosterol regulates sterol regulatory element binding protein (SREBP) cleavage in fission yeast.
Porter, J. R., Burg, J. S., Espenshade, P. J., & Iglesias, P. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.144337 · Cited by 36
Singh, A. B., Kan, C. F. K., Shende, V., Dong, B., & Liu, J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m049429 · Cited by 35
Monoterpenoid biosynthesis by engineered microbes
Liu, Y., Ma, X., Liang, H., Stephanopoulos, G., & Zhou, K. (2021) · Journal of Industrial Microbiology and Biotechnology · doi:10.1093/jimb/kuab065 · Cited by 34
Segatto, M., Trapani, L., Lecis, C., & Pallottini, V. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2012.02450.x · Cited by 34
Singh, A. B., Li, H., Kan, C. F. K., Dong, B., Nicolls, M. R., & Liu, J. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.301131 · Cited by 32
Singh, A. B., Dong, B., Kraemer, F. B., Xu, Y., Zhang, Y., & Liu, J. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.311122 · Cited by 31
Therapeutic Roles of Statins in Gynecology and Obstetrics: The Current Evidence
Zeybek, B., Costantine, M., Kilic, G. S., & Borahay, M. A. (2018) · Reproductive Sciences · doi:10.1177/1933719117750751 · Cited by 31
“They act by inhibiting the rate-limiting enzyme of cholesterol biosynthesis, 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase, which catalyzes the conversion of HMG to mevalonate.(1) The inhibition of mevalonate synthesis leads to subsequent inhibition of downstream products of this pathway, such as farnesyl pyroph…”
BackgroundCould statins constitute a novel treatment for endometriosis? Systematic review of the literature
Gibran, L., Maranhão, R. C., Abrão, M. S., Baracat, E. C., & Podgaec, S. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.05.028 · Cited by 29
“Among the most important for cellular function, are the pathways that lead to protein isoprenylation: farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP) [2].”
BackgroundMembrane cholesterol as regulator of human rhomboid protease RHBDL4.
Paschkowsky, S., Recinto, S. J., Young, J. C., Bondar, A.-N., & Munter, L. M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002640 · Cited by 29
“Simvastatin is a Food and Drug Administration-approved drug to lower cholesterol synthesis by inhibiting hydroxy-3-methylglutaryl–CoA reductase, the rate-limiting enzyme of cholesterol synthesis (29).”
BackgroundSidaway, J., Wang, Y., Marsden, A. M., Orton, T. C., Westwood, F. R., Azuma, C. T., & Scott, R. C. (2009) · Xenobiotica · doi:10.1080/00498250802585539 · Cited by 28
Jones, R. J., Gu, D., Bjorklund, C. C., Kuiatse, I., Remaley, A. T., Bashir, T., Vreys, V., & Orlowski, R. Z. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204958 · Cited by 26
“We also examined the other major cholesterol transporter, ABCG1 (Wang et al., 2004), and HMGcoR, which regulates cholesterol production (Goldstein and Brown, 1990).”
BackgroundThe role of cholesterol in Mycoplasma membranes
Dahl, J. (1993) · Subcellular Biochemistry · doi:10.1007/978-1-4615-2924-8_5 · Cited by 26
Transmembrane Protein 55B Is a Novel Regulator of Cellular Cholesterol Metabolism
Medina, M. W., Bauzon, F., Naidoo, D., Theusch, E., Stevens, K., Schilde, J., Schubert, C., Mangravite, L. M., Rudel, L. L., Temel, R. E., et al. (2014) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302806 · Cited by 24
“sterol-dependent transcription factors SREBF1 and SREBF2 (aka SREBP1 and 2).(10) We queried publicly available SREBF2 ChIP-Seq data sets,(11) and found evidence for SREBF2binding motifs in the promoter region of the TMEM55B gene (chr14:20 929 629–20 930 186; GRCh37/hg19) in both HepG2 and a human immortalized LCL (Fig…”
Background25-Hydroxycholesterol regulates cholesterol homeostasis in the murine CATH.a neuronal cell line
Waltl, S., Patankar, J. V., Fauler, G., Nusshold, C., Üllen, A., Eibinger, G., Wintersperger, A., Kratky, D., Malle, E., & Sattler, W. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.01.014 · Cited by 24
Goto, D., Okimoto, T., Ono, M., Shimotsu, H., Abe, K., Tsujita, Y., & Kuwano, M. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2707 · Cited by 23
Rye, M. B., Bertilsson, H., Andersen, M. K., Rise, K., Bathen, T. F., Drabløs, F., & Tessem, M.-B. (2018) · BMC Cancer · doi:10.1186/s12885-018-4373-y · Cited by 21
“The mechanisms of translational regulation of HMGCR are not well known, but may involve feedback regulation from side-products of the cholesterol pathway [46].”
BackgroundXu, J., Xu, P., Wu, M., Chen, H., Xu, J., Wu, M., Li, M., & Qian, F. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s91748 · Cited by 20
Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis
Ye, W.-C., Huang, S.-F., Hou, L.-J., Long, H.-J., Yin, K., Hu, C. Y., & Zhao, G.-J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.688546 · Cited by 19
“Cellular cholesterol maintains homeostasis by regulating cholesterol synthesis, cholesterol efflux, and cholesterol uptake from lipoprotein carriers (1, 2).”
BackgroundSahid, M. N. A., Liu, S., Kiyoi, T., & Maeyama, K. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.08.026 · Cited by 17
“The mevalonate pathway is important for production of not only cholesterol molecules but also lipid molecules that are used in the posttranslational modification of proteins with farnesyl pyrophosphate and geranylgeranyl pyrophosphate (Goldstein and Brown, 1990; Greenwood et al., 2006).”
BackgroundSmall Heterodimer Partner Regulates Dichotomous T Cell Expansion by Macrophages
Shahoei, S. H., Kim, Y.-C., Cler, S. J., Ma, L., Anakk, S., Kemper, J. K., & Nelson, E. R. (2019) · Endocrinology · doi:10.1210/en.2019-00025 · Cited by 16
“all cell types have some capacity to synthesize or catabolize cholesterol (9, 10).”
BackgroundHuman β-migrating very low density lipoprotein induces foam cell formation in human mesangial cells
Anami, Y., Kobori, S., Sakai, M., Kasho, M., Nishikawa, T., Yano, T., Matsuda, H., Matsumura, T., Takemura, T., & Shichiri, M. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00166-4 · Cited by 16
“Since the LDL receptor is, however, well known to be down-regulated by accumulation of cholesteryl esters [33,34], the possible existence of another as yet unidentified, pathway for foam cell formation by bVLDL in long-term incubation is indicated.”
BackgroundThe molecular basis of the anticancer effect of statins
Buccioli, G., Testa, C., Jacchetti, E., Pinoli, P., Carelli, S., Ceri, S., & Raimondi, M. T. (2024) · Scientific Reports · doi:10.1038/s41598-024-71240-6 · Cited by 13
“One of the genes targeted by statins is HMGCR, responsible for the inhibition of mevalonate pathway and prenylation 45 .”
BackgroundFan, Q.-W., Iosbe, I., Asou, H., Yanagisawa, K., & Michikawa, M. (2001) · AGE · doi:10.1007/s11357-001-0001-9 · Cited by 13
Quinn, T. R., Steussy, C. N., Haines, B. E., Lei, J., Wang, W., Sheong, F. K., Stauffacher, C. V., Huang, X., Norrby, P.-O., Helquist, P., et al. (2021) · Chemical Science · doi:10.1039/d1sc00102g · Cited by 12
Bowling, N., Matter, W. F., Gadski, R. A., McClure, D. B., Schreyer, T., Dawson, P. A., & Vlahos, C. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37462-9 · Cited by 11
Ames, R. (2017) · Microorganisms · doi:10.3390/microorganisms5010003 · Cited by 10
“The second part of the pathway converts mevalonate to IPP and DMAPP through several intermediaries and the action of multiple enzymes.”
BackgroundYuet, W. C., Ebert, D., & Jann, M. (2021) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098620959271 · Cited by 8
Biochemistry, cell biology and molecular biology of lipids ofSaccharomyces cerevisiae
Daum, G., Lees, N. D., Bard, M., & Dickson, R. (1998) · Yeast · doi:10.1002/(sici)1097-0061(199812)14:16<1471::aid-yea353>3.0.co;2-y
Metadata
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature
- Published
- 1990-02
- Volume
- 343
- Issue
- 6257
- Pages
- 425-430
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2071124826
- Cited by
- 5,394
- References
- 84
- Citations by year
- 2026: 78 · 2025: 101 · 2024: 104 · 2023: 123 · 2022: 143 · 2021: 145 · 2020: 152 · 2019: 147 · 2018: 138 · 2017: 126 · 2016: 146 · 2015: 189 · 2014: 201 · 2013: 180 · 2012: 161
- FWCI
- 33.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
- Keywords
- mevalonate pathway, terpenoids, feedback regulation, LDL receptor, cholesterol biosynthesis, growth regulation, cancer therapy, heart disease
- MeSH terms
- Animals, Cell Division, Cholesterol, Farnesol, Gene Expression Regulation, Humans, Hydroxymethylglutaryl CoA Reductases, Hydroxymethylglutaryl-CoA Synthase, Mevalonic Acid, Receptors, LDL, Sterols, Transcription, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.